Connection
Amit Tiwari to Histone Deacetylase Inhibitors
This is a "connection" page, showing publications Amit Tiwari has written about Histone Deacetylase Inhibitors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.335 |
|
|
|
-
Shirbhate E, Singh V, Kore R, Koch B, Veerasamy R, Tiwari AK, Rajak H. Synergistic strategies: histone deacetylase inhibitors and platinum-based drugs in cancer therapy. Expert Rev Anticancer Ther. 2025 Feb; 25(2):121-141.
Score: 0.234
-
Shirbhate E, Singh V, Jahoriya V, Mishra A, Veerasamy R, Tiwari AK, Rajak H. Dual inhibitors of HDAC and other epigenetic regulators: A novel strategy for cancer treatment. Eur J Med Chem. 2024 Jan 05; 263:115938.
Score: 0.054
-
Shirbhate E, Veerasamy R, Boddu SHS, Tiwari AK, Rajak H. Histone deacetylase inhibitor-based oncolytic virotherapy: A promising strategy for cancer treatment. Drug Discov Today. 2022 06; 27(6):1689-1697.
Score: 0.048